London: A low cost diabetes drug could benefit breast cancer sufferers.
"However, patients could benefit from metformin, which cuts off this fuel supply. There is more work to do but this test could be an important new way of tailoring treatments to a patient`s needs, across a range of cancers." Last year it was reported that metformin was being tested to see if it can stop the growth of lung cancers. Researchers from Manchester and Thomas Jefferson University in the US studied 219 breast cancer patients and worked out which ones had tumours that fed on high-energy foods, known as ketones and lactate, found in healthy cells. IANS
Tejas closer to induction into IAF
No plans to drop charges against Khobragade: US
`Dhoom 3` audience verdict
Lieutenant Governor Najeeb Jung recommends President`s rule in Delhi